SAHA : FDA approved histone deacetylase inhibitor demonstrates exceptionally high inhibition of corneal haze following PRK surgery in rabbit model [abstract]

dc.contributor.author	Waggoner, Michael	eng
dc.contributor.author	Tandon, Ashish	eng
dc.contributor.author	Tovey, Jonathan	eng
dc.contributor.author	Sharma, Ajay	eng
dc.contributor.author	Lopez, Vanessa	eng
dc.contributor.author	Cowden, John W.	eng
dc.contributor.author	Rieger, Frank G., III	eng
dc.contributor.author	Hamm, Chuck W.	eng
dc.contributor.meetingname	Health Sciences Research Day (2010 : University of Missouri)	eng
dc.date.issued	2010	eng
dc.description.abstract	TGF[beta] induces the transformation of corneal keratocytes into fibroblasts and myofibroblasts resulting in the formation of corneal haze (scar) following injury. We investigated whether epigenetic modifications can prevent development of corneal haze in vivo using a rabbit model.	eng
dc.format.extent	1 page	eng
dc.identifier.uri	http://hdl.handle.net/10355/9407
dc.language	English	eng
dc.relation.ispartofcommunity	University of Missouri--Columbia. Health Sciences Research Day	eng
dc.rights	OpenAccess.	eng
dc.rights.license	This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.	eng
dc.subject	eye injury	eng
dc.subject	occluded vision	eng
dc.title	SAHA : FDA approved histone deacetylase inhibitor demonstrates exceptionally high inhibition of corneal haze following PRK surgery in rabbit model [abstract]	eng
dc.type	Abstract	eng

2010 Health Sciences Research Day (MU)
Poster presentation abstracts for 2010 Health Sciences Research Day.